title: IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination.
abstract: The insulin like growth factor receptor subtype 1(IGF-1R) plays an important role in cancers transformation and progression. The aim is to investigate the effects of sunitinib on IGF-1R cell signaling transduction, especially on receptor phosphorylation and ubiquitination. In HEK293 cells, IGF-1R signaling pathways are activated in response to IGF-1, which induces obvious phosphorylations of receptor tyrosine and Akt, ERK. However, the phosphorylations of receptor tyrosine, Akt and ERK were significant inhibited by sunitinib. We found that both IGF-1 and sunitinib obviously down regulated the IGF-1R expression. For analysis the ubiquitination, HEK293 cells were simulated with 100 ng/ml IGF-1 or 10 nM sunitinib for 10 min after serum starvation for 24 h. Both IGF-1 and sunitinib could obviously induce the IGF-1R ubiquitination at 10 min compared with control (only serum free, no stimulation), indicating IGF-1 and sunitinib down-regulate the IGF-1R by increasing the receptor degradation through ubiquitination dependent proteasome pathway. We also found that MDM2 combined to IGF-1R in response to sunitinib stimulation. To confirm it, HEK293 cells were transfected with human HA-MDM2 (+MDM2) or siRNA to MDM2 (-MDM2). Following 24 h serum starvation, cells were stimulated with 10 nM sunitinib for 10 min. In over-expressed MDM2 cells, IGF-1R was more ubiquitinated than that in mock-transfected cells (control), and no ubiquitination in -MDM2 cells. These results mean that sunitinib mediates ubiquitination of IGF-1R dependent on MDM2. In summary, sunitinib could block signaling transduction and mediate degradation of IGF-1R.
authors: Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan 250021, China.
authors: Hongchang
authors: H
authors: Shen
authors: Yan
authors: Y
authors: Fang
authors: Wei
authors: W
authors: Dong
authors: Xueru
authors: X
authors: Mu
authors: Qi
authors: Q
authors: Liu
authors: Jiajun
authors: J
authors: Du
keywords: Insulin like growth factor; MDM2; Phosphorylation and ubiquitination; Tyrosine kinase inhibitor
references: Nature. 1993 Apr 29;362(6423):841-4
references: 7683111
references: Nat Rev Drug Discov. 2007 Sep;6(9):734-45
references: 17690708
references: Cancer Control. 2007 Jul;14(3):285-94
references: 17615535
references: Mol Cancer Ther. 2003 May;2(5):471-8
references: 12748309
references: J Biol Chem. 2005 Jul 1;280(26):24412-9
references: 15878855
references: Biochim Biophys Acta. 1997 Jun 7;1332(3):F105-26
references: 9196021
references: Int J Cancer. 2005 Jan 10;113(2):316-28
references: 15386423
references: Clin Exp Metastasis. 2003;20(8):757-66
references: 14713109
references: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8247-52
references: 12821780
references: Cancer Res. 2008 Jul 15;68(14):5669-77
references: 18632619
references: Cancer Cell. 2003 May;3(5):439-43
references: 12781361
references: Endocr Rev. 1995 Feb;16(1):3-34
references: 7758431
references: J Clin Endocrinol Metab. 2006 Oct;91(10):4070-6
references: 16849418
references: Blood. 2003 May 1;101(9):3597-605
references: 12531805
references: Horm Res. 2006;65 Suppl 1:3-8
references: 16508327
references: Mol Cell Biol. 2003 May;23(9):3363-72
references: 12697834
references: Hum Pathol. 2003 Aug;34(8):803-8
references: 14506643
references: Cancer Res. 2003 Feb 1;63(3):627-35
references: 12566306
references: Endocr Relat Cancer. 2007 Sep;14(3):781-90
references: 17914107
references: Mol Cancer Ther. 2002 Dec;1(14):1349-53
references: 12516969
references: Clin Cancer Res. 2003 Jan;9(1):327-37
references: 12538485
references: Cancer Res. 2004 Jan 1;64(1):236-42
references: 14729630
references: Hum Pathol. 2002 Aug;33(8):801-5
references: 12203212
references: Endocr Rev. 1995 Apr;16(2):143-63
references: 7540132